Role of central cholinergic receptor sub-types in spatial working memory: A five-arm maze task in mice provides evidence for a functional role of nicotinic receptors in mediating trace access processes

Neuroscience

Volumn 120, Issue 4, 2003, Pages 1049-1059

  Maviel, T ^a   Durkin, T P ^a  

^a CNRS   (France)

Author keywords

Attention; Mecamylamine; Muscarinic receptors; Retrieval; Scopolamine

Indexed keywords

CHOLINERGIC RECEPTOR; MECAMYLAMINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; SCOPOLAMINE; SODIUM CHLORIDE;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECALL; RECEPTOR BLOCKING; SPATIAL MEMORY; TASK PERFORMANCE; TRAINING; WORKING MEMORY;

EID: 0042133317     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00403-2     Document Type: Article

References (64)

1. Aigner T.G., Walker D.L., Mishkin M. Comparison of the effects of scopolamine administered before and after acquisition in a test of visual recognition memory in monkeys. Behav Neural Biol. 55:1991;61-67.
2. Andrews J.S., Jansen J.H.M., Linders S., Princen A. Effects of disrupting the cholinergic system on short-term spatial memory in rats. Psychopharmacology. 115:1994;485-494.
3. Ballard T.M., McAllister K.H. The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats. Psychopharmacology (Berl). 146:1999;10-18.
4. Baxter M.G., Bucci D.J., Gorman L.K., Wiley R.G., Gallagher M. Selective immunotoxic lesions of basal forebrain cholinergic cells effects on learning and memory in rats . Behav Neurosci. 109:1995;714-722.
5. Baxter M.G., Chiba A.A. Cognitive functions of the basal forebrain. Curr Opin Neurobiol. 9:1999;178-183.
6. Beatty W.W., Shavalia A.D. Spatial memory in rats time course of working memory and effect of anesthetics . Behav Neural Biol. 28:1980;454-462.
7. Beatty W.W., Bierley R.A. Scopolamine degrades spatial working memory but spares spatial reference memory dissimilarity of anticholinergic effects and restriction of distal visual cues . Pharmacol Biochem Behav. 23:1985;1-6.
8. Beatty W.W., Bierley R.A. Scopolamine impairs encoding and retrieval of spatial working memory in rats. Physiol Psychol. 14:1986;82-86.
9. Beatty W.W., Butters N., Janowsky D.S. Patterns of memory failure after scopolamine treatment implications for cholinergic hypotheses of dementia . Behav Neural Biol. 45:1986;196-211.
10. Bohdanecky Z., Jarvik M., Carley J. Differential impairment of delayed matching in monkeys by scopolamine and scopolamine methylbromide. Psychopharmacologia. 11:1967;293-299.
11. Brioni J.D., Decker M.W., Sullivan J.P., Arneric S.P. The pharmacology of (-) nicotine and novel cholinergic channel modulators. Adv Pharmacol. 37:1997;153-214.
12. Broks P., Preston G.C., Traub M., Poppleton P., Ward C., Staub S.M. Modelling dementia effects of scopolamine on memory and attention . Neuropsychologia. 26:1988;685-700.
13. Bymaster F.P., Heath I., Hendrix J.C., Shannon H.E. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J Pharmacol Exp Ther. 267:1993;16-24.
14. Changeux J.P., Bertrand D., Corringer P.J., Dehaene S., Edelstein S., Léna C., Le Novère N., Marubio L., Piciotto M., Zoli M. Brain nicotinic receptors structure and regulation, role in learning and reinforcement . Brain Res Rev. 26:1998;198-216.
15. Cheal M. Scopolamine disrupts maintenance of attention rather than memory processes. Behav Neural Biol. 33:1981;163-187.
16. Collerton D. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience. 19:1986;1-28.
17. Cozzolino R., Guaraldi D., Giuliani A., Ghirardi O., Ramacci M.T., Angelucci L. Effect of concomitant nicotinic and muscarinic blockade on spatial memory disturbance in rats are purely additive evidence from the Morris water maze task . Physiol Behav. 56:1994;111-114.
18. Decker M.W., Majchrzak M.J. Effects of systemic and intracerbroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats. Psychopharmacology. 107:1992;530-534.
19. Dunne M.P., Hartley L.R. Scopolamine and the control of attention in humans. Psychopharmacology. 89:1986;94-97.
20. Durkin T.P., Messier C., De Boer P., Westerink B.H.C. Raised glucose levels enhance scopolamine-induced acetylcholine overflow from the hippocampus an in vivo microdialysis study in the rat . Behav Brain Res. 49:1992;181-188.
21. Durkin T.P. Spatial working memory over long retention intervals dependence on sustained cholinergic activation in the septohippocampal or nucleus basalis magnocellularis-cortical pathways . Neuroscience. 62:1994;681-693.
22. Durkin T.P., Cazala P., Garcia R. Trans-synaptic mechanisms controlling cholinergic neuronal activation in the septo-hippocampal and NBM-cortical pathways differential roles in memory and attentional processes? Numan R. The behavioral neuroscience of the septal region. 2000;146-174 Springer-Verlag, New York.
23. Durkin T.P., Beaufort C., Leblond L., Maviel T. A five-arm maze enables parallel measures of sustained visuo-spatial attention and spatial working memory in mice. Behav Brain Res. 116:2000;39-53.
24. Elrod K., Buccafusco J.J., Jackson W.J. Nicotine enhances delayed matching to sample performance by primates. Life Sci. 43:1988;277-287.
25. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Annu Rev Psychol. 48:1997;649-684.
26. Flood J.F., Cherkin A. Scopolamine effects on memory retention in mice a model of dementia? Behav Neural Biol. 45:1986;169-184.
27. Granon S., Poucet B., Thinus-Blanc C., Changeux J.-P., Vidal C. Nicotinic and muscarinic receptors in the rat prefrontal cortex differential roles in working memory, response selection and effortful processing . Psychopharmacology. 119:1995;139-144.
28. Hagan J.J., Morris R.G.M. The cholinergic hypothesis of memory a review of animal experiments . Iversen L.L., Iversen S.D., Snyder S.H. Handbook of psychopharmacology, Vol. 20. 1988;237-323 Plenum, New York.
29. Haroutunian V., Barnes E., Davis K.L. Cholinergic modulation of memory in rats. Psychopharmacology. 87:1985;266-271.
30. Hasselmo M.E., Wyble B.P., Wallenstein G.V. Encoding and retrieval of episodic memories role of cholinergic and GABAergic modulation in the hippocampus . Hippocampus. 6:1996;693-708.
31. Jones G.M.M., Sahakian B.J., Levy R., Warburton D.M., Gray J.A. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology. 108:1992;485-494.
32. Jones S., Sudweeks S., Yakel J.L. Nicotinic receptors in the brain correlating physiology with function . Trends Neurosci. 22:1999;555-561.
33. Kikusui T., Tonohiro T., Kaneko T. The allocentric place discrimination task is selectively and highly dependent on the central muscarinic system in rats. Pharmacol Biochem Behav. 65:2000;131-139.
34. Leblond L., Beaufort C., Delerue F., Durkin T.P. Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a five-arm maze protocol in mice. Behav Brain Res. 128:2002;91-102.
35. Levin E.D., McGurk S., South D., Butcher L.L. Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze. Behav Neural Biol. 51:1989;270-271.
36. Levin E.D., Rose J.E., McGurk S., Butcher L.L. Characterization of the cognitive effects of combined muscarinic and nicotinic blockade. Behav Neural Biol. 53:1990;103-112.
37. Levin E.D., Rose J. Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze. Brain Res Bull. 27:1991;125-128.
38. Levin E.D., Kaplan S., Boardman A. Acute nicotine interactions with nicotinic and muscarinic antagonists working and reference memory effects in the 16-arm radial maze . Behav Pharmacol. 8:1997;236-242.
39. Levin E.D., Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl). 138:1998;217-230.
40. Levin E.D., Revzani A.H. Development of nicotinic drug therapy for cognitive disorders. Eur J Pharmacol. 393:2000;141-146.
41. Little J.T., Johnson D.N., Minichiello M., Weingartner H., Sunderland T. Combined nicotinic and muscarinic blockade in elderly normal volunteers cognitive, behavior, and physiologic responses . Neuropsychopharmacology. 19:1998;60-69.
42. McGaughy J., Turchi J., Sarter M. Crossmodal divided attention in rats effects of chlordiazepoxide and scopolamine . Psychopharmacology. 115:1994;213-220.
43. Moran P.M. Differential roles of scopolamine and mecamylamine on working and reference memory in the rat. Pharmacol Biochem Behav. 45:1993;533-538.
44. Muir J.L., Page K.J., Sirinathsinghji D.J., Robbins T.W., Everitt B.J. Excitotoxic lesions of basal forebrain cholinergic neurones effects on learning, memory and attention . Behav Brain Res. 57:1993;123-131.
45. Muir J.L., Everitt B.J., Robbins T.W. AMPA-induced excitotoxic lesions of the basal forebrain a significant role for the cortical cholinergic system in attentional function . J Neurosci. 14:1994;2313-2326.
46. Musco E., Wise R.A. Locomotion induced by ventral tegmental micro-injections of a nicotinic agonist. Pharmacol Biochem Behav. 35:1990;735-737.
47. Newhouse P.A., Potter A., Levin E.D. Nicotinic system involvement in Alzheimer's disease and Parkinson's disease implications for therapeutics . Drugs Aging. 11:1997;206-228.
48. Ohno M., Yamamoto T., Watanabe S. Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats. Pharmacol Biochem Behav. 45:1993;89-93.
49. Olton D.S., Givens B.S., Markowska A.M., Shapiro M., Golski S. Mnemonic functions of the cholinergic septo-hippocampal system. Squire L.R., Weinberger N.M., Lynch G., McGaugh J.L. Memory: organization and locus of change. 1992;250-269 Oxford University Press, Oxford.
50. Park S., Knopick C., McGurk S., Meltzer H.Y. Nicotine impairs spatial working memory while leaving spatial attention intact. Neuropsychopharmacology. 22:2000;200-209.
51. Penetar D.M., McDonough J.H. Effects of cholinergic drugs on delayed match-to-sample performance of rhesus monkeys. Pharmacol Biochem Behav. 19:1983;963-967.
52. Perry E., Martin-Ruiz C., Lee M., Griffiths M., Johnson M., Piggott M., Haroutunian V., Buxbaum J.D., Näsland J., Davis K., Gotti C., Clementi F., Tzartos S., Cohen O., Soreq H., Jaros E., Perry R., Ballard C., McKeith I., Court J. Nicotinic receptor sub-types in human brain ageing, Alzheimer and Lewy body diseases. Eur J Pharmacol. 393:2000;215-222.
53. Pilcher J., Sessions G., McBride S. Scopolamine impairs spatial working memory in the radial maze an analysis by error type and arm choice . Pharmacol Biochem Behav. 58:1997;449-459.
54. Porter A., Bymaster F., DeLapp N., Yamada M., Wess J., Hamilton S., Nathanson N., Felder C. M1 muscarinic receptor signaling in mouse hippocampus and cortex. Brain Res. 944:2002;82-89.
55. Rusted J.M., Warburton D.M. Effects of scopolamine on working memory of healthy young adults. Psychopharmacology. 96:1988;145-152.
56. Sahakian B., Jones G., Levy R., Gray J., Warburton D. The effects of nicotine on attention, information processing and short-term memory in patients with dementia of the Alzheimer type. Br J Psychol. 154:1989;797-800.
57. Sarter M., Bruno J.P. Cognitive functions of cortical acetylcholine toward a unifying hypothesis . Brain Res Revs. 23:1997;28-46.
58. Sarter M., Bruno J.P. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents . Neuroscience. 95:2000;933-952.
59. Terry A.V. Jr, Buccafusco J.J., Jackson W.J. Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys. Pharmacol Biochem Behav. 45:1993;925-929.
60. Toumane A., Durkin T.P. Time gradient for post-test vulnerability to scopolamine-induced amnesia following the initial acquisition session of a spatial reference memory task in mice. Behav Neural Biol. 60:1993;139-151.
61. Turchi J., Sarter M. Cortical acetylcholine and processing capacity effects of cortical cholinergic deafferentation on crossmodal divided attention in rats . Cogn Brain Res. 6:1997;147-158.
62. Viscardi A.P., Heise G.A. Effects of scopolamine on components of delayed response performance in the rat. Pharmacol Biochem Behav. 25:1986;633-639.
63. Voytko M.L., Olton D.S., Richardson R.T., Gorman I.K., Tobin J.R., Price D.L. Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci. 14:1994;167-186.
64. Wenk G.L., Hughey D.S., Olton D.S. Basal forebrain cholinergic neurones and Alzheimer's disease. Coyle J.T. Animal models of dementia: a synaptic neurochemical perspective. 1987;187-216 Alan R. Liss, New York.